Halt Medical, Inc. Receives Canadian License for Fibroid Treatment Device
Published: Oct 19, 2010
About Halt Medical, Inc.
Halt Medical, Inc. is a medical device design and manufacturing company based near San Francisco, CA developing products to ablate tissue with its next generation RFVTA system. The Halt system has been cleared by the FDA for general use and is currently being studied in the US and Latin America for relief of symptoms caused by uterine fibroids. Halt is preparing to commercialize the Halt Fibroid System in markets outside the US where it has already been approved for general surgical and fibroid indications. The worldwide business opportunity for the Halt Fibroid System is estimated to be over $2billion annually.
Information about the Halt Fibroid Study and a list of clinical sites in the U.S. may be found at www.clinicaltrials.gov, study number NCT00874029.
SOURCE Halt Medical, Inc.